Clinical Scorecard: RA App Overestimates Active Disease
At a Glance
Category
Detail
Condition
Key Mechanisms
Patient-derived joint counts may confirm low disease activity or remission but are less reliable for identifying active disease.
Target Population
Care Setting
Key Highlights
Smartphone app showed modest agreement with physician joint counts.
Patient-reported assessments had high positive predictive value for low disease activity (95%) but limited sensitivity (54%) and negative predictive value (50%) for detecting active disease.
Patients reported higher joint counts than physicians, especially for swollen joints.
Modest agreement may reflect real-world differences and comorbid conditions.
Guideline-Based Recommendations
Diagnosis
Use physician assessments as primary predictors of disease activity.
Incorporate in-person assessments to enhance accuracy.
Management
Consider patient-derived counts for confirming low disease activity or remission.
Monitoring & Follow-up
Regularly assess both patient-reported and physician-assessed joint counts.
Risks
Overestimation of active disease due to reliance on patient-reported data.
Patient & Prescribing Data
App-based assessments may not accurately reflect disease activity in cases with poor control.
Clinical Best Practices
Incorporate both patient-reported and physician assessments in disease monitoring.
Provide in-person or video instruction to enhance app-based training.
In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.
